Back to Research

Organization profile

Centenara Labs

Centenara Labs is a longevity-focused biotechnology holding company that develops and invests in therapies targeting the biological hallmarks of aging to expand human healthspan. The organization builds a diversified portfolio of clinical and pre-clinical ventures addressing vision loss, cancer, fibrosis, and sarcopenia.11

Baar, SwitzerlandFounded 2013

Overview

1. Executive Summary (Confidence: High)

Centenara Labs, formerly known as Rejuveron Life Sciences AG, is a prominent player in the Swiss and global longevity biotechnology sector.[11] Founded and chaired by entrepreneur Christian Angermayer, the firm operates as a venture-builder and strategic investor, focusing on the "Hallmarks of Aging".[11] Centenara employs a platform-based model to de-risk the development of longevity drugs by spreading investment across multiple technologies and clinical indications.[11] Its portfolio currently includes several clinical-stage assets, most notably through Endogena Therapeutics, which is developing regenerative treatments for ophthalmology.[11] With a leadership team of experienced drug developers and a scientific advisory board featuring aging research luminaries, Centenara is strategically positioned to translate breakthrough discoveries into approved geriatric therapies.[11]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.